ESMO 2019: Seven promising liquid biopsy companies at the conference - 2 views
-
Alex Parker on 27 Sep 19Research and development (R&D) in liquid biopsy is increasingly being funded by both public and private sectors due to its promising features such as early detection of cancer tumour, new lesion characterisation and identification of cancer drug target.